Security
Anika Therapeutics Inc. Common Stock · ANIK
ANIKNASDAQCommon stockCurrentCIK 898437Updated Nov 7, 2026
Name history
ANIKA THERAPEUTICS INC · through Mar 13, 2014ANIKA RESEARCH INC · through Nov 27, 1996
ANIK price & chart
Loading TradingView…
NASDAQ:ANIK on TradingView ↗About the company
Anika Therapeutics, Inc. (NASDAQ: ANIK), is the global leader in the design, development, manufacturing, and commercialization of hyaluronic acid innovations. In partnership with clinicians, our sole focus is dedicated to delivering and advancing osteoarthritis pain management and orthopedic regenerative solutions. At our core is a passion to deliver a differentiated portfolio that improves patient outcomes around the world. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
In the news
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ↗
Seeking Alpha
Anika Therapeutics, Inc. (ANIK) Q3 2026 Earnings Call Transcript ↗
Anika Therapeutics, Inc. 2026 Q3 - Results - Earnings Call Presentation ↗
Anika Therapeutics GAAP EPS of -$0.02 misses by $0.08, revenue of $30.59M beats by $1.15M ↗
SEC disclosures
Anika Therapeutics, Inc. files 8-K: Material Event ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
144 filing
SCHEDULE 13G/A - filed by VANGUARD CAPITAL MANAGEMENT LLC regarding Anika Therapeutics, Inc.
S-8 filing
Show 5 more recent filings
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
SCHEDULE 13G/A - filed by BlackRock Portfolio Management LLC regarding Anika Therapeutics, Inc.
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03, 9.01
4 filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 189,437,000Source | 231,405,000Source | 183,474,000Source | 187,682,000Source | 262,655,000Source | 179,387,000Source | 190,605,000Source | 263,744,000Source | 190,270,000Source | 202,740,000Source | 270,632,000Source | 349,128,000Source |
| Property, Plant and Equipment, NetUSD | 40,684,000Source | 44,572,000Source | 40,102,000Source | 41,083,000Source | 47,685,000Source | 39,722,000Source | 40,461,000Source | 46,057,000Source | 40,324,000Source | 38,994,000Source | 46,198,000Source | 48,279,000Source |
| GoodwillUSD | 8,051,000Source | 7,656,000Source | 7,825,000Source | 8,056,000Source | 7,350,000Source | 7,892,000Source | 7,423,000Source | 7,403,000Source | 8,054,000Source | 7,125,000Source | 7,571,000Source | 7,339,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 1,650,000Source | 3,081,000Source | 1,650,000Source | 1,661,000Source | 3,969,000Source | 1,650,000Source | 2,281,000Source | 4,297,000Source | 1,650,000Source | 2,490,000Source | 4,626,000Source | 74,599,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 57,990,000Source | 62,368,000Source | 38,412,000Source | 53,167,000Source | 62,822,000Source | 41,020,000Source | 53,371,000Source | 68,629,000Source | 57,481,000Source | 55,629,000Source | 72,867,000Source | 86,327,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 22,187,000Source | 28,357,000Source | 29,062,000Source | 23,955,000Source | 33,773,000Source | 25,768,000Source | 21,987,000Source | 32,077,000Source | 23,690,000Source | 23,594,000Source | 35,961,000Source | 34,627,000Source |
| Inventory, NetUSD | 16,284,000Source | 39,629,000Source | 28,565,000Source | 16,922,000Source | 51,464,000Source | 22,838,000Source | 21,336,000Source | 49,408,000Source | 18,787,000Source | 23,809,000Source | 46,386,000Source | 39,765,000Source |
| Assets, CurrentUSD | 101,590,000Source | 136,106,000Source | 99,190,000Source | 99,317,000Source | 155,000,000Source | 93,561,000Source | 102,509,000Source | 158,962,000Source | 103,358,000Source | 113,652,000Source | 163,309,000Source | 169,547,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 5,129,000Source | 5,752,000Source | 3,151,000Source | 5,273,000Source | 6,941,000Source | 3,935,000Source | 5,815,000Source | 8,848,000Source | 3,400,000Source | 5,494,000Source | 8,095,000Source | 8,828,000Source |
| Operating Lease, Right-of-Use AssetUSD | 24,226,000Source | 27,208,000Source | 24,949,000Source | 24,722,000Source | 27,765,000Source | 25,430,000Source | 25,180,000Source | 28,181,000Source | 25,939,000Source | 25,685,000Source | 28,767,000Source | 30,696,000Source |
| Other Assets, NoncurrentUSD | 5,507,000Source | 11,310,000Source | 3,023,000Source | 5,550,000Source | 19,524,000Source | 4,303,000Source | 5,725,000Source | 17,571,000Source | 4,034,000Source | 5,656,000Source | 18,672,000Source | 17,219,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — | 0Source |
| Common Stock, Value, IssuedUSD | 144,000Source | 147,000Source | 134,000Source | 144,000Source | 148,000Source | 133,000Source | 143,000Source | 148,000Source | 139,000Source | 144,000Source | 147,000Source | 146,000Source |
| Retained Earnings (Accumulated Deficit)USD | 60,495,000Source | 93,532,000Source | 59,040,000Source | 62,824,000Source | 123,450,000Source | 55,731,000Source | 66,794,000Source | 123,538,000Source | 60,787,000Source | 71,667,000Source | 128,052,000Source | 210,719,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -4,939,000Source | -5,701,000Source | -5,329,000Source | -4,755,000Source | -6,416,000Source | -5,310,000Source | -6,103,000Source | -6,315,000Source | -4,959,000Source | -6,783,000Source | -5,943,000Source | -6,443,000Source |
| Stockholders' Equity Attributable to ParentUSD | 146,805,000Source | 179,864,000Source | 137,282,000Source | 147,672,000Source | 210,338,000Source | 133,901,000Source | 148,397,000Source | 208,536,000Source | 143,465,000Source | 153,989,000Source | 212,265,000Source | 285,563,000Source |
| Additional Paid in Capital, Common StockUSD | 91,105,000Source | 91,886,000Source | 83,437,000Source | 89,459,000Source | 93,156,000Source | 83,347,000Source | 87,563,000Source | 91,165,000Source | 87,498,000Source | 88,961,000Source | 90,009,000Source | 81,141,000Source |
| Liabilities and EquityUSD | 189,437,000Source | 231,405,000Source | 183,474,000Source | 187,682,000Source | 262,655,000Source | 179,387,000Source | 190,605,000Source | 263,744,000Source | 190,270,000Source | 202,740,000Source | 270,632,000Source | 349,128,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 19,089,000Source | 25,493,000Source | 22,147,000Source | 16,081,000Source | 26,121,000Source | 20,966,000Source | 17,901,000Source | 28,460,000Source | 21,908,000Source | 23,306,000Source | 31,059,000Source | 27,914,000Source |
| Operating Lease, Liability, CurrentUSD | 1,725,000Source | 2,292,000Source | 1,935,000Source | 1,815,000Source | 2,287,000Source | 1,942,000Source | 1,874,000Source | 2,129,000Source | 2,052,000Source | 1,918,000Source | — | — |
| Accounts Payable, CurrentUSD | 4,732,000Source | 6,805,000Source | 6,236,000Source | 4,771,000Source | 9,994,000Source | 6,339,000Source | 5,277,000Source | 10,022,000Source | 6,041,000Source | 5,617,000Source | 9,860,000Source | 9,074,000Source |
| Operating Lease, Liability, NoncurrentUSD | 22,782,000Source | 25,242,000Source | 23,315,000Source | 23,173,000Source | 25,789,000Source | 23,794,000Source | 23,563,000Source | 26,344,000Source | 24,196,000Source | 24,014,000Source | 26,904,000Source | 28,817,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 6,436,000Source |
| Other Liabilities, NoncurrentUSD | 761,000Source | 806,000Source | 730,000Source | 756,000Source | 407,000Source | 726,000Source | 744,000Source | 404,000Source | 701,000Source | 772,000Source | 404,000Source | 398,000Source |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | — | — | — | 4,987,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation and amortization | — | — | — | — | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 6,641,000Source | 2,863,000Source | 10,084,000Source | 13,130,000Source | 15,243,000Source | 14,315,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 2,180,000Source | -3,034,000Source | -408,000Source | -3,366,000Source | 1,305,000Source | 5,630,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 5,407,000Source | -523,000Source | -30,000Source | 9,424,000Source | 11,396,000Source | 6,873,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 745,000Source | 47,000Source | 42,000Source | -2,506,000Source | -11,000Source | 1,965,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | 108,000Source | 18,000Source | -7,000Source | 260,000Source | -6,327,000Source | -5,270,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -4,846,000Source | -130,000Source | 11,188,000Source | 5,403,000Source | -1,788,000Source | 4,409,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -1,239,000Source | 1,672,000Source | -401,000Source | -8,334,000Source | -5,427,000Source | -7,486,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 1,431,000Source | 2,824,000Source | 6,826,000Source | 7,734,000Source | 5,427,000Source | 7,486,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 1,657,000Source | 1,467,000Source | 1,566,000Source | 2,599,000Source | 2,152,000Source | 934,000Source |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 8,690,000Source | 3,971,000Source | 9,485,000Source | 10,914,000Source | 5,000,000Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -10,347,000Source | -5,438,000Source | -10,551,000Source | -12,729,000Source | -6,324,000Source | -4,852,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -16,461,000Source | -3,788,000Source | 322,000Source | -15,708,000Source | -13,460,000Source | -8,059,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 1,076,000Source | 3,993,000Source | 3,117,000Source | 106,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | 3,394,000Source | 1,833,000Source | 2,548,000Source | 6,641,000Source | 2,995,000Source | 10,216,000Source | 12,158,000Source | 15,243,000Source | 14,315,000Source |
| Amortization of Intangible AssetsUSD | — | — | 0Source | 200,000Source | — | 200,000Source | — | 200,000Source | 400,000Source | 700,000Source | 7,800,000Source | 7,800,000Source |
| DepreciationUSD | — | — | 1,400,000Source | 1,300,000Source | 1,500,000Source | 1,300,000Source | 1,400,000Source | 1,200,000Source | 5,400,000Source | 5,000,000Source | 6,400,000Source | 6,700,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | — | — | -400,000Source | -200,000Source | 100,000Source | -500,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | 166,000Source | -2,864,000Source | -1,917,000Source | 0Source |
| GoodwillUSD | — | — | 8,051,000Source | 7,656,000Source | 7,825,000Source | 8,056,000Source | 7,892,000Source | 7,423,000Source | 8,054,000Source | 7,125,000Source | 7,571,000Source | 7,339,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | — | — | 62,190,000Source | — |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | — | — | — | — | — | — | — | 2,462,000Source | 62,190,000Source | 0Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -3,175,000Source | -1,845,000Source | 3,309,000Source | -4,647,000Source | -5,056,000Source | -3,958,000Source | -9,979,000Source | -8,828,000Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 845,000Source | -28,073,000Source | 0Source | 677,000Source | — | -915,000Source | -901,000Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 846,000Source | -28,073,000Source | 0Source | 677,000Source | 0Source | -915,000Source | -901,000Source | -47,557,000Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | 939,000Source | 2,170,000Source | 71,000Source | 681,000Source | 235,000Source | 89,000Source | 672,000Source | 6,064,000Source | -2,660,000Source | -3,887,000Source |
| Inventory Write-downUSD | — | — | — | — | — | — | 1,032,000Source | 832,000Source | 5,821,000Source | 44,708,000Source | 3,341,000Source | 5,329,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,329,000Source | -29,918,000Source | 3,309,000Source | -3,970,000Source | -5,056,000Source | -4,873,000Source | -10,880,000Source | -56,385,000Source | -82,667,000Source | -14,859,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | 0Source | 0Source | 76,000Source | 23,000Source | 16,000Source |
| Gain (Loss) on Disposition of Assets | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Gain (Loss) on Disposition of Business | — | — | — | — | — | — | — | —Source | — | — | — | — |
| Restructuring Costs | — | — | — | — | — | — | —Source | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 27,817,000Source | 29,559,000Source | 32,610,000Source | 28,219,000Source | 29,612,000Source | 26,168,000Source | 112,819,000Source | 119,907,000Source | 166,662,000Source | 156,236,000Source |
| Cost of RevenueUSD | — | — | 12,233,000Source | 10,151,000Source | 11,366,000Source | 13,856,000Source | 10,615,000Source | 11,487,000Source | 49,012,000Source | 43,909,000Source | 63,574,000Source | 62,660,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 11,871,000Source | 13,543,000Source | 10,949,000Source | 12,230,000Source | 17,772,000Source | 12,906,000Source | 49,088,000Source | 55,555,000Source | 95,847,000Source | 84,794,000Source |
| Operating Income (Loss)USD | — | — | -3,233,000Source | -81,000Source | 2,954,000Source | -4,180,000Source | -5,488,000Source | -4,284,000Source | -11,051,000Source | -5,101,000Source | -87,639,000Source | -19,400,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -2,236,000Source | 325,000Source | 3,380,000Source | -3,966,000Source | -4,821,000Source | -3,869,000Source | -9,307,000Source | -2,764,000Source | -85,327,000Source | -18,746,000Source |
| Income Tax Expense (Benefit)USD | — | — | 939,000Source | 2,170,000Source | 71,000Source | 681,000Source | 235,000Source | 89,000Source | 672,000Source | 6,064,000Source | -2,660,000Source | -3,887,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,329,000Source | -29,918,000Source | 3,309,000Source | -3,970,000Source | -5,056,000Source | -4,873,000Source | -10,880,000Source | -56,385,000Source | -82,667,000Source | -14,859,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.16Source | -2.03Source | 0.25Source | -0.28Source | -0.37Source | -0.34Source | -0.76Source | -3.83Source | -5.64Source | -1.02Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.16Source | -2.03Source | 0.24Source | -0.28Source | -0.37Source | -0.34Source | -0.76Source | -3.83Source | -5.64Source | -1.02Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 14,419,000Source | 14,768,000Source | 13,330,000Source | 14,364,000Source | 13,531,000Source | 14,297,000Source | 14,339,000Source | 14,721,000Source | 14,656,000Source | 14,561,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 14,419,000Source | 14,768,000Source | 13,717,000Source | 14,517,000Source | 13,531,000Source | 14,297,000Source | 14,339,000Source | 14,721,000Source | 14,656,000Source | 14,561,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 0Source | 200,000Source | — | 200,000Source | — | 200,000Source | 400,000Source | 700,000Source | 7,800,000Source | 7,800,000Source |
| Costs and ExpensesUSD | — | — | 18,817,000Source | 19,489,000Source | 18,290,000Source | 18,543,000Source | 24,485,000Source | 18,965,000Source | 74,858,000Source | 81,099,000Source | 190,727,000Source | 112,976,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 611,000Source | 5,835,000Source | 3,774,000Source | 1,386,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 1,407,000Source | 1,383,000Source | 5,372,000Source | 6,884,000Source | 6,434,000Source | 6,704,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | — | — | -400,000Source | -200,000Source | 100,000Source | -500,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Gross ProfitUSD | — | — | 15,584,000Source | 19,408,000Source | 21,244,000Source | 14,363,000Source | 18,997,000Source | 14,681,000Source | 63,807,000Source | 75,998,000Source | 103,088,000Source | 93,576,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -3,175,000Source | -1,845,000Source | 3,309,000Source | -4,647,000Source | -5,056,000Source | -3,958,000Source | -9,979,000Source | -8,828,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -10,247,000Source | -4,078,000Source | -86,061,000Source | -19,080,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | -0.22Source | -0.12Source | 0.25Source | -0.33Source | -0.37Source | -0.28Source | -0.7Source | -0.6Source | — | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | -0.22Source | -0.12Source | 0.24Source | -0.33Source | -0.37Source | -0.28Source | -0.7Source | -0.6Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 845,000Source | -28,073,000Source | 0Source | 677,000Source | — | -915,000Source | -901,000Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 846,000Source | -28,073,000Source | 0Source | 677,000Source | 0Source | -915,000Source | -901,000Source | -47,557,000Source | — | — |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | 997,000Source | 406,000Source | 426,000Source | 214,000Source | 667,000Source | 415,000Source | 1,744,000Source | 2,337,000Source | 2,312,000Source | 654,000Source |
| Research and Development ExpenseUSD | — | — | 6,946,000Source | 5,946,000Source | 7,341,000Source | 6,313,000Source | 6,713,000Source | 6,059,000Source | 25,770,000Source | 25,544,000Source | 32,690,000Source | 28,182,000Source |
| Restructuring Costs | — | — | — | — | — | — | —Source | — | — | — | — | — |
Filing attachments
d106406dex991.htm · 8-K · 2026-02-26
EX-99.1 3 d106406dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Anika Reports Fourth Quarter and Full Year 2025 Financial Results Met 2025 revenue and exceeded revised adjusted EBITDA; reaffirms 2026 revenue and sets adjusted EBITDA target Commercial Channel grew 22% and 15% for Q4 and full year, respectively Generated $11.2 million operating cash flow and $4.4 million in free cash flow for the full year FDA response for Hyalofast ® PMA received in January 2026, Anika developing responses for…
Read attachment ↗d136217dex991.htm · 8-K · 2026-01-08
Exhibit 99.1 Anika Therapeutics Announces Leadership Transition Stephen (Steve) Griffin, Current Chief Financial Officer and Chief Operating Officer, Appointed President and Chief Executive Officer Cheryl Blanchard to Become Executive Chair of the Board of Directors BEDFORD, Mass. - January 8, 2026 - Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today ann…
Read attachment ↗